Ovid Therapeutics Inc.

OVID ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014
Assets
Cash & Equivalents $87.1M $51.9M $69.9M $4.8M
Accounts Receivable
Inventory
Total Current Assets $88.6M $52.4M
Property, Plant & Equipment $51.8K $43.6K
Goodwill
Intangible Assets (Excl. Goodwill) $124.2K $110.1K
Total Assets $89.5M $53.0M
Liabilities
Accounts Payable $2.0M $857.2K
Total Current Liabilities $6.0M $3.7M
Long-Term Debt
Total Liabilities $6.0M $3.7M
Stockholders' Equity
Retained Earnings $-100.7M $-35.9M
Total Stockholders' Equity $83.4M $49.3M $68.1M $4.7M
← Newer Page 2 of 2 Older →